NLRP3 and polycystic ovary syndrome: Low-grade inflammation lies at the base of all metabolic conditions as well as PCOS, and several studies showed that ketone body β-hydroxybutyrate (BHB) is capable of taming inflammation through several mechanisms such as inhibition of NLRP3 and some interleukins, likely also via microbiome modulation [20,21].